Preparation of thioesterase domains (VinTE, HlsTE, and GfsTE)
5'-GGTGTGGATCCTGCAAAACGGTCTAC, and a TE domain from FD-891 biosynthetic pathway (GfsTE) 4 was also cloned with primers GfsTE-N 5'-CGCATATGGGGGGCGGCACC-3' GfsTE-C and 5'-TCATCTCTCGAGATCAGGACAGGG-3' using with PrimeStar Polymerase (Takara) according to the manufacture's protocol. Appropriate cosmid DNAs were used as template for PCR. Desired plasmid clones in pT7Blue vector were digested with appropriate restriction enzymes and the DNA fragments were ligated to linearized pET28a vector via the corresponding restriction sites. HlsTE and GfsTE were expressed and purified in the same manner as VinTE.
Site-directed mutagenesis:
Single amino acid mutation in VinTE was introduced by QuikChange (Stratagene) method according to the manufacturer's protocol with the primer 5'-GTCCTCCTCGGCTACgCGGCTGGCGGTGTC-3' and its complemented oligonucleotide. The obtained mutant proteins (S136A) was purified in the same manner as the wild type of VinTE and used for the enzymatic assay.
Enzymatic assay (a general method)
One mL of 10 mM ω-hydroxy fatty acid ethyl esters in DMSO and 9 mL of TE protein (final 60-300 M) in 100 mM sodium phosphate buffer (pH 7.0) were mixed and the mixture was incubated at 28°C for 24 hr. Enzymatic reaction products were extracted with excess amount of CHCl 3 and the dried extract was purified by silica-gel chromatography.
Preparation of ω ω-hydroxy fatty acid ethyl esters
Ethyl 6-hydroxyhexanoate (compound 1, 6-hydroxyhexanoic acid ethyl ester) was purchased from Aldrich.
Ethyl 8-hydroxyoctanoate 2 (8-hydroxyoctanoic acid ethyl ester) 5, 6 8-Octanolide (86 mg) was treated with 5 mL of ethanol and 0.3 mL of sulfuric acid under refluxing condition for 6 hr. The reaction mixture was neutralized with sat. NaHCO 3 solution. After removal of ethanol, the residue was extracted with CHCl 3 and the extract was dried over MgSO 4 . The solvent was removed and the residue was purified by silica-gel chromatography to afford 2 (54 mg, 44% 6 1,6-Hexanediol (TCI, 2.0 g, 17 mmol) was dissolved in 30 mL of CH 2 Cl 2 and followed by addition of p-toluenesulfonic acid (0.2 g) and 3,4-dihydro-2H-pyran (1.6 mL) at 0°C. After stirring for 1.5 hr at 0°C, the solution was washed with sat. NaHCO 3 and brine, and then dried over Na 2 SO 4 . After removal of the solvent, the residue was purified by silica-gel chromatography to afford mono-THP-ether (1.2 g, 35%).
Ethyl (2E)-8-hydroxy-2-octenoate 3 ((2E)-8-hydroxy-2-octenoic acid ethyl ester)
THP protected compound was then added to a mixture of oxalyl chloride (0.8 mL) and DMSO (0.9 mL) in 40 mL of CH 2 Cl 2 at -78°C. After stirring for 2 hr at -78°C, triethylamine (4.3 mL) was added and the mixture was stirred for 5 min at -78°C. The reaction temperature was gradually raised up to room temperature. The reaction was quenched with water, and the mixture was extracted with CH 2 Cl 2 . The organic layer was washed with brine, and then dried over Na 2 SO 4 .
After removal of the solvent, the aldehyde was used for the next reaction without purification.
NaH (134 mg) was reacted with triethyl phosphonoacetate (789 mg) in THF solution (5 mL) at 0°C. After 0.5 hr at 0°C, the aldehyde (700 mg) in 15 mL THF was added into the solution.
After 1 hr, sat. NH 4 Cl solution was added and the product was extracted with CH 2 Cl 2 . The organic layer was washed with water and brine, and then dried over Na 2 SO 4 . After removal of the solvent, the residue was treated with p-toluenesulfonic acid in ethanol (10 mL) at room temperature for 1.5
hr. After removal of the solvent, the residue was purified by silica-gel chromatography to afford 3 (443 mg, 37% in 3 steps THP ether of 3-bromo-1-propanol (4.1 g, 18.3 mmol) in 20 mL of acetonitrile was mixed with PPh 3 (7.5 g, 28.5 mmol) and K 2 CO 3 (4.0 g, 28.7 mmol). The mixture was refluxed for 19 hr.
The residual solid was filtered and the solvent was removed by evaporator. The residue was dissolved in CHCl 3 and followed by addition of excess amount of diethyl ether to give phosphonium bromide (5.2 g, crude).
The phosphonium bromide (4.5 g) was dissolved in anhydrous THP under argon atmosphere and KHMDS toluene solution (25 mL, 13 mmol) was added at -78°C, followed by ethyl 8-oxooctanoate (2.4 g, 12 mmol). The reaction temperature was gradually raised up to room temperature and the solution was stirred for 10 hr at room temperature. The reaction was quenched by addition of water and the mixture was extracted with diethyl ether and washed with brine. After removal of the solvent, the residue was purified by silica-gel chromatography to afford THP protected 5 (1.3 g, 32%), which was then treated with PPTS (0.35 g, 1.4 mmol) in ethanol (30 mL)
at 55°C for 5 hr. After removal of the solvent, the residue was purified by silica-gel chromatography to afford 5 (0.45 g, 48% 
N-Acetylcysteamine thioester of (2E,4E,6S,7S,8E)-6,12-dihydroxy-2,4,6-trimethyldodeca-2,4,8-trienoic acid 6
To a solution of 6-triisopropylsilyl ether of ethyl ester of 6 (100 mg, 0.221 mmol) in THF was added tetrabutylammonium fluoride (531 L, 0.531 mmol) at 0°C. The mixture was warmed to room temperature, and was stirred for 1 hr. The resulting solution was re-cooled to 0°C, the reaction was quenched by addition of aq. NH 4 Cl solution. The mixture was diluted with ethyl acetate. The organic layer was separated, and the aqueous portion was extracted with ethyl acetate.
The combined organic layer was washed with brine and dried over Na 2 SO 4 . After evaporation of the solvent, the residue was purified by silica gel column chromatography to afford 80 mg of diol 
Ethyl (9Z)-18-hydroxy-9-octadecenate 8 ((9Z)-18-hydroxy-9-octadecenoic acid ethyl ester)
1,9-Nonanediol (Aldrich, 4.1 g, 25.7 mmol) was dissolved in 90 mL of CH 2 Cl 2 and triethylamine (20 mL, 144 mmol) and p-toluenesulfonyl chloride (5.1 g, 26.8 mmol) were added. After stirring for 20 min at room temperature, water was added and the mixture was extracted with CHCl 3 . The organic layer was washed with water and dried over Na 2 SO 4 . After removal of the solvent, the residue was purified by silica-gel chromatography to afford monotosylate (3.6 g, 45%). The monotosylate (3.5 g, 11.3 mmol) was dissolved in DMF (28 mL) and NaBr (7.0 g, 67.6 mmol) was added. After stirring for 3 hr at 50°C, the mixture was extracted with ethyl acetate.
The organic layer was washed with water and dried over Na 2 SO 4 . After removal of the solvent, the residue was purified by silica-gel chromatography to afford 9-bromo-1-nonanol (2.0 g, 80% 9-Bromo-1-nonanol (2.0 g, 9.0 mmol) was dissolved in 18 mL of CH 2 Cl 2 , and 3,4-dihydro-2H-pyran (4.0 mL, 44 mmol) and PPTS (0.55 g, 2.2 mmol) were added. After stirring for 20 min at room temperature, the mixture was extracted with CHCl 3 . The organic layer was washed with water and dried over Na 2 SO 4 . After removal of the solvent, the residue was purified by silica-gel chromatography to afford THP-ether of 9-bromo-1-nonanol (2.7 g, 98% 
Characterization of VinTE reaction products

From compound 1 (a mixture of cyclic trimer 12 and cyclic tetramer 13)
One mL of 1 in DMSO (4.1 mg, final 2.6 mM) and 9 mL of VinTE (final 60 M) in 100 mM sodium phosphate buffer (pH 7.0) were mixed and incubated at 28°C for 24 hr. Enzymatic reaction products were extracted with chloroform and the extract was purified by silica-gel chromatography (hexane/ethyl acetate, 2:1) to obtain 1.7 mg of cyclic products (12 : 13 = 5 : 1). 3 (a mixture of cyclic dimer 16 and cyclic trimer 17, plus linear polymers) 
13
One mL of 3 in DMSO (4.0 mg, final 2.1 mM) and 9 mL of VinTE (final 60 M) in 100 mM sodium phosphate buffer (pH 7.0) were mixed and incubated at 28°C for 24 hr. Enzymatic reaction products were extracted with chloroform and the extract was purified by silica-gel chromatography 
One mL of 4 in DMSO (5.0 mg, final 2 mM) and 9 mL of VinTE (final 60 M) in 100 mM sodium phosphate buffer (pH 7.0) were mixed and incubated at 28°C for 24 hr. Enzymatic reaction products were extracted with CHCl 3 and the extract was purified by silica-gel chromatography (hexane/ethyl acetate, 9:1) to obtain 2.1 mg of cyclic product 18 and 1.5 mg of linear dimer 19. From compound 5 (cyclic dimer 20 and linear dimer 21)
One mL of 5 in DMSO (4.8 mg, final 2 mM) and 9 mL of VinTE (final 60 M) in 100 mM sodium phosphate buffer (pH 7.0) were mixed and incubated at 28°C for 24 hr. Enzymatic reaction products were extracted with CHCl 3 and the extract was purified by silica-gel chromatography (hexane/ethyl acetate, 20:1) to obtain 2.0 mg of cyclic product 20 and 1.3 mg of linear dimer 21. 
From compound 6 (cyclic dimer 22)
A reaction mixture (final volume; 2.2 mL of phosphate buffer pH 7.0) containing 6 mg of NAC thioester 6 in 0.2 mL of DMSO, and ca. 30 mg (0.3 mM) of VinTE was incubated at 28°C overnight.
The mixture was diluted with ethyl acetate. The organic layer was separated, and the aqueous portion was extracted with ethyl acetate. The combined organic layer was filtered through a pad of Celite. After evaporation of the solvent under reduced pressure, the residue was purified by silica gel column chromatography to afford 2 mg of 22; VinTE: vicenistatin PKS TE, PikTE: pikromycin PKS TE, Debs TE: erythromycin PKS TE, GfsTE:
FD-891 PKS TE, HlsTE: halstoctacosanolide PKS TE. Yellow shows an active site serine residue (S136 in VinTE). The marked S136, D163, and H282 of VinTE resemble a catalytic triad, which is conserved in TE domains.
